Literature DB >> 6339790

Microbiologic aspects of chronic ambulatory peritoneal dialysis.

S I Vas.   

Abstract

Mesh:

Substances:

Year:  1983        PMID: 6339790     DOI: 10.1038/ki.1983.15

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  35 in total

Review 1.  New developments and concepts in antimicrobial therapy for intra-abdominal infections.

Authors:  Z Younes; D A Johnson
Journal:  Curr Gastroenterol Rep       Date:  2000-08

Review 2.  Establishment of aging biofilms: possible mechanism of bacterial resistance to antimicrobial therapy.

Authors:  H Anwar; J L Strap; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1992-07       Impact factor: 5.191

3.  Kinetic interaction of biofilm cells of Staphylococcus aureus with cephalexin and tobramycin in a chemostat system.

Authors:  H Anwar; J L Strap; J W Costerton
Journal:  Antimicrob Agents Chemother       Date:  1992-04       Impact factor: 5.191

4.  Amikacin pharmacokinetics during continuous ambulatory peritoneal dialysis.

Authors:  B D Smeltzer; M S Schwartzman; J S Bertino
Journal:  Antimicrob Agents Chemother       Date:  1988-02       Impact factor: 5.191

5.  Pharmacokinetics of single-dose intravenous, oral, and intraperitoneal pefloxacin in patients on chronic ambulatory peritoneal dialysis.

Authors:  J L Schmit; L Hary; P Bou; H Renaud; P F Westeel; M Andrejak; A Fournier
Journal:  Antimicrob Agents Chemother       Date:  1991-07       Impact factor: 5.191

6.  Our war against bacteria in peritoneal dialysis, the last 40 years!

Authors:  Dimitrios G Oreopoulos; Antonios H Tzamaloukas
Journal:  Int Urol Nephrol       Date:  2008       Impact factor: 2.370

7.  Fatal fungal peritonitis in an adolescent on continuous ambulatory peritoneal dialysis: association with deferoxamine.

Authors:  M Nakamura; W B Weil; D B Kaufman
Journal:  Pediatr Nephrol       Date:  1989-01       Impact factor: 3.714

8.  In vitro bactericidal activities of gentamicin, cefazolin, and imipenem in peritoneal dialysis fluids.

Authors:  D C Halstead; J Guzzo; J A Giardina; A E Geshan
Journal:  Antimicrob Agents Chemother       Date:  1989-09       Impact factor: 5.191

9.  Effect of dialysate fluids on phagocytosis and killing by normal neutrophils.

Authors:  D M Harvey; K J Sheppard; A G Morgan; J Fletcher
Journal:  J Clin Microbiol       Date:  1987-08       Impact factor: 5.948

10.  Use of home automated intermittent peritoneal dialysis in the treatment of end stage renal failure.

Authors:  P K Li; A Y Wang; C B Leung; S F Lui; K N Lai
Journal:  Int Urol Nephrol       Date:  1994       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.